Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Ku GY"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-13 z 13
    Tytuł:
    Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survival.
    Autorzy:
    Ku GY
    Yuan J
    Page DB
    Schroeder SE
    Panageas KS
    Carvajal RD
    Chapman PB
    Schwartz GK
    Allison JP
    Wolchok JD
    Ku, Geoffrey Y
    Yuan, Jianda
    Page, David B
    Schroeder, Sebastian E A
    Panageas, Katherine S
    Carvajal, Richard D
    Chapman, Paul B
    Schwartz, Gary K
    Allison, James P
    Wolchok, Jedd D
    Pokaż więcej
    Źródło:
    Cancer (0008543X); 4/1/2010, Vol. 116 Issue 7, p1767-1775, 9p
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Cystic lymphangioma causing intussusception of the right colon: a case report and review of current literature.
    Autorzy:
    Park JH; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Park J; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Ku GY; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Moon DK; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Ahn JS; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Kim HJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Kim MJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Park JW; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Ryoo SB; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Jeong SY; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Park KJ; Department of Surgery, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul, 03080, Korea.
    Pokaż więcej
    Źródło:
    Journal of surgical case reports [J Surg Case Rep] 2023 Nov 20; Vol. 2023 (11), pp. rjad628. Date of Electronic Publication: 2023 Nov 20 (Print Publication: 2023).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinical Utility of F-2-Fluoro-deoxy-d-glucose PET Imaging in Locally Advanced Esophageal/Gastroesophageal Junction Adenocarcinoma.
    Autorzy:
    Cowzer D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Keane F; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Ku GY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.; Department of Medicine, Weill Cornell University, New York, NY 10065, USA.
    Pokaż więcej
    Źródło:
    Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2023 May 28; Vol. 13 (11). Date of Electronic Publication: 2023 May 28.
    Typ publikacji:
    Journal Article; Review
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Lobular Carcinoma In Situ during Preoperative Biopsy and the Rate of Upgrade.
    Autorzy:
    Lee J; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Ku GY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Lee H; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Park HS; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Ku JS; Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
    Kim JY; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Park S; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Park BW; Department of Surgery, Yonsei University College of Medicine, Seoul, Korea.
    Pokaż więcej
    Źródło:
    Cancer research and treatment [Cancer Res Treat] 2022 Oct; Vol. 54 (4), pp. 1074-1080. Date of Electronic Publication: 2021 Dec 21.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Breast Carcinoma In Situ*/diagnosis
    Breast Carcinoma In Situ*/pathology
    Breast Carcinoma In Situ*/surgery
    Breast Neoplasms*/diagnosis
    Breast Neoplasms*/surgery
    Calcinosis*/diagnosis
    Calcinosis*/surgery
    Carcinoma in Situ*/pathology
    Carcinoma, Intraductal, Noninfiltrating*/diagnosis
    Carcinoma, Intraductal, Noninfiltrating*/pathology
    Carcinoma, Intraductal, Noninfiltrating*/surgery
    Carcinoma, Lobular*/diagnosis
    Carcinoma, Lobular*/pathology
    Carcinoma, Lobular*/surgery
    Biopsy ; Female ; Humans ; Receptors, Progesterone
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Can F-FDG PET/CT Radiomics Features Predict Clinical Outcomes in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma?
    Autorzy:
    Jayaprakasam VS; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Gibbs P; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Gangai N; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Bajwa R; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Sosa RE; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Yeh R; Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Greally M; Mater Private Hospital, D07 WKW8 Dublin, Ireland.
    Ku GY; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Gollub MJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Paroder V; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2022 Jun 20; Vol. 14 (12). Date of Electronic Publication: 2022 Jun 20.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience.
    Autorzy:
    Glassman DC; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Palmaira RL; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Covington CM; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Desai AM; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Ku GY; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Li J; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Harding JJ; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Varghese AM; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    O'Reilly EM; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA.
    Yu KH; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, NY, USA. .; Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2018 Jun 27; Vol. 18 (1), pp. 693. Date of Electronic Publication: 2018 Jun 27.
    Typ publikacji:
    Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Fluorouracil/*administration & dosage
    Irinotecan/*administration & dosage
    Pancreatic Neoplasms/*drug therapy
    Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Irinotecan/adverse effects ; Liposomes ; Male ; Middle Aged ; Mutation ; Nanoparticles ; Pancreatic Neoplasms/mortality ; Proto-Oncogene Proteins p21(ras)/genetics ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Phase II Trial of Sorafenib in Patients with Chemotherapy Refractory Metastatic Esophageal and Gastroesophageal (GE) Junction Cancer.
    Autorzy:
    Janjigian YY; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States of America.
    Vakiani E; Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States of America.
    Ku GY; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States of America.
    Herrera JM; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States of America.
    Tang LH; Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States of America.
    Bouvier N; Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Sloan Kettering Institute, New York, United States of America.
    Viale A; Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Sloan Kettering Institute, New York, United States of America.
    Socci ND; Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Sloan Kettering Institute, New York, United States of America; Departments of Bioinformatics, Sloan Kettering Institute, New York, United States of America.
    Capanu M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, United States of America.
    Berger M; Departments of Pathology, Memorial Sloan Kettering Cancer Center, New York, United States of America; Marie-Josée & Henry R. Kravis Center for Molecular Oncology, Sloan Kettering Institute, New York, United States of America.
    Ilson DH; Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, United States of America.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2015 Aug 14; Vol. 10 (8), pp. e0134731. Date of Electronic Publication: 2015 Aug 14 (Print Publication: 2015).
    Typ publikacji:
    Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Adenocarcinoma/*drug therapy
    Antineoplastic Agents/*therapeutic use
    Drug Resistance, Neoplasm/*drug effects
    Esophageal Neoplasms/*drug therapy
    Esophagogastric Junction/*pathology
    Niacinamide/*analogs & derivatives
    Phenylurea Compounds/*therapeutic use
    Stomach Neoplasms/*drug therapy
    Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Adult ; Aged ; Disease-Free Survival ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Esophagogastric Junction/drug effects ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Niacinamide/therapeutic use ; Sorafenib ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Analysis
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Depression, cytokines, and pancreatic cancer.
    Autorzy:
    Breitbart W; Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
    Rosenfeld B
    Tobias K
    Pessin H
    Ku GY
    Yuan J
    Wolchok J
    Pokaż więcej
    Źródło:
    Psycho-oncology [Psychooncology] 2014 Mar; Vol. 23 (3), pp. 339-45. Date of Electronic Publication: 2013 Oct 18.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Adenocarcinoma/*blood
    Cytokines/*blood
    Depression/*blood
    Pancreatic Neoplasms/*blood
    Adenocarcinoma/psychology ; Adult ; Aged ; Aged, 80 and over ; Analysis of Variance ; Anxiety Disorders/complications ; Case-Control Studies ; Depression/diagnosis ; Depression/psychology ; Depressive Disorder/complications ; Fatigue/etiology ; Female ; Humans ; Male ; Middle Aged ; New York City ; Pain/complications ; Pancreatic Neoplasms/psychology ; Psychiatric Status Rating Scales/statistics & numerical data ; Sleep Wake Disorders/complications
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Bevacizumab in combination with oxaliplatin and doxorubicin or liposomal doxorubicin for hepatocellular cancer: a case series.
    Autorzy:
    Ku GY; Johns Hopkins Singapore International Medical Centre, Singapore.
    De Lima Lopes G Jr
    Chang AY
    Pokaż więcej
    Źródło:
    Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2011 Jun; Vol. 7 (2), pp. 174-9. Date of Electronic Publication: 2010 Dec 22.
    Typ publikacji:
    Case Reports; Journal Article
    MeSH Terms:
    Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
    Carcinoma, Hepatocellular/*drug therapy
    Liver Neoplasms/*drug therapy
    Adult ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal, Humanized ; Bevacizumab ; Doxorubicin/administration & dosage ; Humans ; Male ; Middle Aged ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Optimization and validation of a robust human T-cell culture method for monitoring phenotypic and polyfunctional antigen-specific CD4 and CD8 T-cell responses.
    Autorzy:
    Lin Y; Ludwig Center for Cancer Immunotherapy, Immunology Program, Sloan-Kettering Institute, Newy York, New York 10021, USA.
    Gallardo HF
    Ku GY
    Li H
    Manukian G
    Rasalan TS
    Xu Y
    Terzulli SL
    Old LJ
    Allison JP
    Houghton AN
    Wolchok JD
    Yuan J
    Pokaż więcej
    Źródło:
    Cytotherapy [Cytotherapy] 2009; Vol. 11 (7), pp. 912-22.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Cell Culture Techniques*
    CD4-Positive T-Lymphocytes/*metabolism
    CD8-Positive T-Lymphocytes/*metabolism
    Neoplasms/*immunology
    Antigens/immunology ; Antigens, CD/metabolism ; Antigens, Differentiation/metabolism ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/pathology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Cancer Vaccines ; Cells, Cultured ; Cytokines/metabolism ; Feasibility Studies ; Humans ; Neoplasms/therapy
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-13 z 13

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies